Hip Replacement Implant Choice More Important Than Surgeon Skills
|
By HospiMedica International staff writers Posted on 15 Sep 2020 |
A new study suggests that long-term survival of a total hip replacement (THR) is primarily due to implant choice decisions, rather than surgical technique.
Researchers at the University of Bristol Medical School (United Kingdom), the University of Exeter (United Kingdom), and other institutions conducted a study that analyzed a UK registry of all THRs performed over 14 years in 461 hospitals. In all, 664,761 patients (mean age 69.9 years, 61.1% female) were compared, with survival of THRs implanted in one exemplary unit, the Royal Devon & Exeter NHS Foundation Trust (RDE; UK) compared to all others. The main outcome was revision surgery of any part of the THR construct for any reason.
The results showed better implant survival at RDE, with an all-cause construct failure of 1.7%, compared with 2.9% in the rest of England, Wales, Northern Ireland, and the Isle of Man. The researchers showed that when the patient's outcomes from RDE were compared to cases nationwide where the same three implants used at the RDE were implanted, there was no difference in how many of the hips lasted 14 years, suggesting that consistent use of a reliable THR implant may be a more important determinant of success than the surgeon performing the operation. The study was published on August 31, 2020, in PLOS Medicine.
“These findings are vitally important to making sure as many of our patients have a good outcome from their hip replacement as possible,” said lead author Jonathan Evans, MD, of the University of Bristol Medical School. “We want patients across the country to feel empowered to ask their surgeon not only what implants they plan to use for their hip replacement, but more importantly to ask for the long-term evidence that the implant works well. If they do not feel happy with the answer, then patients should feel confident asking for another opinion or even vote with their feet and go to a different hospital.”
The National Joint Registry for England, Wales, Northern Ireland and the Isle of Man (NJR) is a national database that has collected data since 2003, and currently contains in excess of one million records of primary THRs. In 2017, the NJR identified at least 415 different hospitals performing THRs, using at least 822 different combinations of femoral stem and acetabular socket. During this time, the RDE used only three.
Related Links:
University of Bristol Medical School
University of Exeter
Royal Devon & Exeter NHS Foundation Trust
Researchers at the University of Bristol Medical School (United Kingdom), the University of Exeter (United Kingdom), and other institutions conducted a study that analyzed a UK registry of all THRs performed over 14 years in 461 hospitals. In all, 664,761 patients (mean age 69.9 years, 61.1% female) were compared, with survival of THRs implanted in one exemplary unit, the Royal Devon & Exeter NHS Foundation Trust (RDE; UK) compared to all others. The main outcome was revision surgery of any part of the THR construct for any reason.
The results showed better implant survival at RDE, with an all-cause construct failure of 1.7%, compared with 2.9% in the rest of England, Wales, Northern Ireland, and the Isle of Man. The researchers showed that when the patient's outcomes from RDE were compared to cases nationwide where the same three implants used at the RDE were implanted, there was no difference in how many of the hips lasted 14 years, suggesting that consistent use of a reliable THR implant may be a more important determinant of success than the surgeon performing the operation. The study was published on August 31, 2020, in PLOS Medicine.
“These findings are vitally important to making sure as many of our patients have a good outcome from their hip replacement as possible,” said lead author Jonathan Evans, MD, of the University of Bristol Medical School. “We want patients across the country to feel empowered to ask their surgeon not only what implants they plan to use for their hip replacement, but more importantly to ask for the long-term evidence that the implant works well. If they do not feel happy with the answer, then patients should feel confident asking for another opinion or even vote with their feet and go to a different hospital.”
The National Joint Registry for England, Wales, Northern Ireland and the Isle of Man (NJR) is a national database that has collected data since 2003, and currently contains in excess of one million records of primary THRs. In 2017, the NJR identified at least 415 different hospitals performing THRs, using at least 822 different combinations of femoral stem and acetabular socket. During this time, the RDE used only three.
Related Links:
University of Bristol Medical School
University of Exeter
Royal Devon & Exeter NHS Foundation Trust
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







